Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Tag: America

Biogen tanks as opicinumab misses Phase II endpoints in MS trial

Americas
Biogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being developed as a potential...

Pharma Giant Eli Lilly Wants to Launch 20 New Drugs by 2023

Americas
Indianapolis-based pharmaceutical giant Eli Lilly LLY -0.64% laid out an ambitious R&D agenda for launching up to 20 new drugs by 2023 during an...

AbbVies Showcased at Digestive Disease Week with New HUMIRA ,Real-World Research and Promising Anti-IL-23 Antibody Late-Breaking Data

Americas
Data presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate to severe Crohn's disease in adult and pediatric...

Merck & Co Inc Final overall survival (OS) dataData from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma To Be Presented at 2016 ASCO Annual Meeting

Americas
Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows...

AbbVie Inc to participate at the UBS Global Health Care Conference

Americas
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and chief financial officer, will...
1...202122...48Page 21 of 48

Popular

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.